Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Evaluation of Decreased Usage of Beta-blockers
2017-002336-17Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Jun 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metoprolol and bisoprolol in myocardial infarction (MI) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Time to composite of all-cause death or recurrent myocardial infarction. Started Jun 2017; status: completed.
02
Drugs
metoprololbisoprolol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2017-002336-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002336-17.